NO16968_2A | R Documentation |
Kaplan-Meier digitized data from NO16968, figure 2A (PMID 26324362). A reported sample size of 1,886 for a primary endpoint of DFS in colorectal cancer.
NO16968_2A
A data frame of 1,886 observations and 3 variables:
time | event time (in years) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (fu_fa, xelox) | |
Schmoll H-J, Tabernero J, Maroun J, et al. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. J Clin Oncol 2015; 33: 3733–40.
summary(NO16968_2A)
kmplot(NO16968_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.